BaeHWZhaoLKanimLEWongPDelamarterRBDawsonEGIntervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix productsSpine.200631121299–130610.1097/01.brs.0000218581.92992.b7
2.
BodenSDSchimandleJHHuttonWCAn experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristicsSpine.1995204412–42010.1097/00007632-199502001-00003
3.
CarrageeEJHurwitzELWeinerBKA critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedSpine J2011116471–49110.1016/j.spinee.2011.04.023
4.
ChangKYMcClendonMDriscollJAFriday, September 28, 2018 4:05–5:05 PM abstracts: basic science of spinal fusion: 235. Peptide amphiphile nanoscaffolds potentiates the delivery of rh-BMP2 in a rabbit spine fusion modelSpine J.2018188S116–S11710.1016/j.spinee.2018.06.500
5.
DeyoRAChingAMatsenLUse of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and chargesSpine.2012373222–23010.1097/BRS.0b013e31821bfa3a
6.
DudaGNGraingerDWFriskMLChanging the mindset in life sciences toward translation: a consensusSci Transl Med20146264264cm21210.1126/scitranslmed.aaa0599
7.
EdelmanERLaMarcoKWilliam Heberden and reverse translationSci Transl Med20157287287fs22010.1126/scitranslmed.aaa2250
8.
El BialyIJiskootWRezaNMFormulation, delivery and stability of bone morphogenetic proteins for effective bone regenerationPharm Res20173461152–117010.1007/s11095-017-2147-x
9.
FuRSelphSMcDonaghMEffectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysisAnn Intern Med201315812890–90210.7326/0003-4819-158-12-201306180-00006
10.
GeigerMLiRHFriessWCollagen sponges for bone regeneration with rhBMP-2Adv Drug Deliv Rev200355121613–162910.1016/j.addr.2003.08.010
11.
HartgerinkJDBeniashEStuppSISelf-assembly and mineralization of peptide-amphiphile nanofibersScience.200129455471684–168810.1126/science.1063187
HsuWKNickoliMSWangJCImproving the clinical evidence of bone graft substitute technology in lumbar spine surgeryGlobal Spine J201224239–24810.1055/s-0032-1315454
14.
HsuELGhodasraJHAshtekarAA comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regenerationTissue Eng Part A20131915–161764–177210.1089/ten.tea.2012.0711
15.
JamesAWLaChaudGShenJA review of the clinical side effects of bone morphogenetic protein-2Tissue Eng Part B Rev2016224284–29710.1089/ten.teb.2015.0357
16.
KisslingSSeidenstueckerMPilzIHSuedkampNPMayrHOBernsteinASustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrierBMC Biotechnol20161614410.1186/s12896-016-0275-8
17.
KurpinskiKJohnsonTKumarSDesaiTLiSMastering translational medicine: interdisciplinary education for a new generationSci Transl Med20146218218fs21210.1126/scitranslmed.3006858
18.
LeeSSHsuELMendozaMGel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesisAdv Healthc Mater201541131–14110.1002/adhm.201400129
19.
LeeSSFyrnerTChenFSulfated glycopeptide nanostructures for multipotent protein activationNat Nanotechnol2017128821–82910.1038/nnano.2017.109
20.
LiRHWozneyJMDelivering on the promise of bone morphogenetic proteinsTrends Biotechnol2001197255–26510.1016/S0167-7799(01)01665-1
21.
LiHJohnsonNRUsasASustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cellsStem Cells Transl Med201329667–67710.5966/sctm.2013-0027
22.
LianTYLimKKThe legacy of William Heberden the Elder (1710–1801)Rheumatology.2004435664–66510.1093/rheumatology/keg007
23.
LiuW-CRobuISPatelRLeuMCVelezMGabriel ChuT-MThe effects of 3D bioactive glass scaffolds and BMP-2 on bone formation in rat femoral critical size defects and adjacent bonesBiomed Mater20149410.1088/1748-6041/9/4/045013
24.
LoboMIbanezBTake a deep (nitric oxide) breath and follow the reverse translational research pathwayEur Heart J201839292726–272910.1093/eurheartj/ehy355
25.
MaparaMThomasBSBhatKMRabbit as an animal model for experimental researchDent Res J (Isfahan)201291111–11810.4103/1735-3327.92960
26.
MataAGengYHenriksonKJBone regeneration mediated by biomimetic mineralization of a nanofiber matrixBiomaterials.201031236004–601210.1016/j.biomaterials.2010.04.013
27.
SchroederGDHsuWKKeplerCKUse of recombinant human bone morphogenetic protein-2 in the treatment of degenerative spondylolisthesisSpine.2016415445–44910.1097/BRS.0000000000001228
28.
SimmondsMCBrownJVEHeirsMKSafety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant dataAnn Intern Med201315812877–88910.7326/0003-4819-158-12-201306180-00005
29.
UristMRBone: formation by autoinductionClin Orthop Relat Res196520023954–10
30.
WancketLMAnimal models for evaluation of bone implants and devices: comparative bone structure and common model usesVet Pathol2015525842–85010.1177/0300985815593124
31.
XieGSunJZhongGLiuCWeiJHydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitroJ Mater Sci Mater Med20102161875–188010.1007/s10856-010-4038-0